CA2125403A1 - Novel tissue plasminogen activator variants - Google Patents
Novel tissue plasminogen activator variantsInfo
- Publication number
- CA2125403A1 CA2125403A1 CA002125403A CA2125403A CA2125403A1 CA 2125403 A1 CA2125403 A1 CA 2125403A1 CA 002125403 A CA002125403 A CA 002125403A CA 2125403 A CA2125403 A CA 2125403A CA 2125403 A1 CA2125403 A1 CA 2125403A1
- Authority
- CA
- Canada
- Prior art keywords
- tissue plasminogen
- plasminogen activator
- novel tissue
- variants
- activator variants
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6456—Plasminogen activators
- C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21069—Protein C activated (3.4.21.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
Biologically active variant tissue plasminogen activators are disclosed. The disclosure focuses on position 276 variants that exhibit enhanced fibrin specificity.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80853791A | 1991-12-16 | 1991-12-16 | |
US808,537 | 1991-12-16 | ||
PCT/US1992/010677 WO1993012225A1 (en) | 1991-12-16 | 1992-12-14 | Novel tissue plasminogen activator variants |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2125403A1 true CA2125403A1 (en) | 1993-06-24 |
CA2125403C CA2125403C (en) | 2002-08-27 |
Family
ID=25199065
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002125403A Expired - Lifetime CA2125403C (en) | 1991-12-16 | 1992-12-14 | Novel tissue plasminogen activator variants |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0618964A4 (en) |
JP (1) | JP3112480B2 (en) |
AU (1) | AU670774B2 (en) |
CA (1) | CA2125403C (en) |
NZ (1) | NZ246432A (en) |
WO (1) | WO1993012225A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6034234A (en) * | 1994-11-17 | 2000-03-07 | Taiho Pharmaceutical Co., Ltd. | Double-stranded oligonucleotide and anticancer agent containing the same as active ingredient |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4766075A (en) * | 1982-07-14 | 1988-08-23 | Genentech, Inc. | Human tissue plasminogen activator |
US4753879A (en) * | 1984-08-27 | 1988-06-28 | Biogen N.V. | Modified tissue plasminogen activators |
US5073494A (en) * | 1985-04-22 | 1991-12-17 | Genentech, Inc. | Human tissue plasminogen activator substituted at position 275 or at positions 275 and 277 |
FR2581652B1 (en) * | 1985-04-22 | 1989-12-22 | Genentech Inc | NEW MUTANTS OF TISSUE ACTIVATOR OF HUMAN PLASMINOGEN |
PT84589B (en) * | 1986-04-02 | 1989-05-09 | Beecham Group Plc | Process for preparing a fibrinolytic enzyme |
NO882226L (en) * | 1987-05-22 | 1988-11-23 | Zymogenetics Inc | FIBRINOLYTIC PROTEINS. |
DE3851259T2 (en) * | 1987-06-04 | 1994-12-15 | Zymogenetics Inc | Mutated t-PA with Kringle replacement. |
WO1988010119A1 (en) * | 1987-06-22 | 1988-12-29 | Genetics Institute, Inc. | Novel thrombolytic proteins |
US4935237A (en) * | 1988-03-21 | 1990-06-19 | Genentech, Inc. | Processes for the preparation of t-PA mutants |
US5037752A (en) * | 1987-10-09 | 1991-08-06 | Monsanto Company | Modified tissue plasminogen activator substituted at cysteine-73 and lysine-277 |
EP0618973B1 (en) * | 1991-12-16 | 1996-11-27 | Genentech, Inc. | t-PA SUBSTITUTION VARIANTS WITH IMPROVED FIBRIN-SPECIFICITY |
-
1992
- 1992-12-14 JP JP05511076A patent/JP3112480B2/en not_active Expired - Lifetime
- 1992-12-14 AU AU32755/93A patent/AU670774B2/en not_active Expired
- 1992-12-14 WO PCT/US1992/010677 patent/WO1993012225A1/en not_active Application Discontinuation
- 1992-12-14 NZ NZ246432A patent/NZ246432A/en unknown
- 1992-12-14 CA CA002125403A patent/CA2125403C/en not_active Expired - Lifetime
- 1992-12-14 EP EP93901389A patent/EP0618964A4/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
JPH07500971A (en) | 1995-02-02 |
EP0618964A1 (en) | 1994-10-12 |
CA2125403C (en) | 2002-08-27 |
AU3275593A (en) | 1993-07-19 |
JP3112480B2 (en) | 2000-11-27 |
EP0618964A4 (en) | 1995-12-06 |
AU670774B2 (en) | 1996-08-01 |
NZ246432A (en) | 1996-06-25 |
WO1993012225A1 (en) | 1993-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69012888D1 (en) | Plasminogen activator. | |
GB2279527B (en) | Low noise active mixer | |
EP0619982A3 (en) | Surgical anchor. | |
HK1014950A1 (en) | Hiv protease inhibitors. | |
EP0657942A3 (en) | Lateral bipolar transistor. | |
EP0649176A3 (en) | Insulated-gate bipolar transistor. | |
WO1999006387A3 (en) | O-substituted hydroxycumaranone derivatives as antitumor and antimetastatic agents | |
EP1825864A3 (en) | Antithrombotic agents | |
FI925166A (en) | Proteolytic enzymes inhibit sackarinderivat | |
CA2125403A1 (en) | Novel tissue plasminogen activator variants | |
NO883963D0 (en) | MODIFIED PLASMINOGEN ACTIVATORS. | |
WO1999002565A3 (en) | Agent for the treatment and/or prophylaxis of microcirculation disorders | |
EP0600596A3 (en) | Improved bipolar transistor. | |
DE69104828T2 (en) | HYDROCYANATION OF CONJUGATED 2-ALKINE CARBONIC ESTERS. | |
AU3410289A (en) | Plasminogen activators with increased fibrin selectivity | |
USD374040S (en) | Top surface for a dice game | |
AU647763B2 (en) | Combined preparation with thrombolytic action | |
ZA976876B (en) | Trombin-activatable plasminogen activator | |
DE68912383D1 (en) | Plasminogen activator and thrombolytic agent. | |
ZA932443B (en) | The purification of plasminogen activator inhibitor 2 by immunoaffinity chromatography. | |
GB9000629D0 (en) | Tissue plasminogen activator | |
IL109735A0 (en) | Tissue plasminogen activator having zymonogenic or fibrin specific properties | |
AU6639894A (en) | Modified recombinant tissue plasminogen activator | |
FR2651956B1 (en) | GRASS AERATORS. | |
AU6371901A (en) | A novel polypeptide, a human signal peptidase 10 and the polynucleotide encodingthe polypeptide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |
Effective date: 20121214 |